Shares of Orthofix International N.V. (NASDAQ:OFIX) have been assigned an average rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $51.88.
Several equities analysts have weighed in on the stock. BidaskClub lowered shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “sell” rating to a “hold” rating in a report on Thursday, July 6th. BTIG Research assumed coverage on shares of Orthofix International N.V. in a report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price on the stock. Langenberg & Company reiterated a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a report on Wednesday, June 14th. Finally, Ladenburg Thalmann Financial Services assumed coverage on shares of Orthofix International N.V. in a report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price on the stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by BNB Daily and is owned by of BNB Daily. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/orthofix-international-n-v-nasdaqofix-receives-51-88-consensus-price-target-from-analysts-updated.html.
Orthofix International N.V. (OFIX) traded up 7.76% during mid-day trading on Friday, reaching $48.33. 487,980 shares of the company were exchanged. Orthofix International N.V. has a 1-year low of $32.51 and a 1-year high of $49.60. The company’s market capitalization is $872.07 million. The company has a 50 day moving average of $45.44 and a 200-day moving average of $40.49.
Orthofix International N.V. (NASDAQ:OFIX) last posted its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. Orthofix International N.V. had a negative net margin of 0.82% and a positive return on equity of 10.03%. Orthofix International N.V.’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.41 EPS. On average, equities research analysts forecast that Orthofix International N.V. will post $1.53 EPS for the current year.
A number of institutional investors have recently bought and sold shares of OFIX. UBS Asset Management Americas Inc. purchased a new position in Orthofix International N.V. during the first quarter valued at $229,000. Comerica Bank bought a new stake in Orthofix International N.V. during the first quarter worth about $783,000. BNP Paribas Arbitrage SA increased its stake in Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. Bank of New York Mellon Corp increased its stake in Orthofix International N.V. by 122.5% in the first quarter. Bank of New York Mellon Corp now owns 242,068 shares of the medical device company’s stock worth $9,236,000 after buying an additional 133,281 shares during the period. Finally, American Century Companies Inc. increased its stake in Orthofix International N.V. by 68.9% in the first quarter. American Century Companies Inc. now owns 175,522 shares of the medical device company’s stock worth $6,696,000 after buying an additional 71,599 shares during the period. Institutional investors own 99.68% of the company’s stock.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.